The president of the German Pharmaceutical Association (ABDA), Thomas Preis, has called on Federal Health Minister Nina Warken to address discounts offered on prescription medications by foreign online pharmacies.
Preis stated that these practices constitute a clear violation of existing legislation and require state intervention to penalize and prevent such occurrences. He emphasized that any entity failing to adhere to established regulations should be excluded from providing services to Germany’s statutory health insurance system. He warned that allowing these practices to continue could jeopardize domestic pharmaceutical supply.
The call for action comes after a recent ruling by the Federal Court of Justice allowed major foreign online pharmacies to once again offer discounts, although the ruling referenced a previous legal framework. Current social legislation explicitly prohibits discounts or bonuses on the redemption of prescription medications. Preis argued that maintaining price stability is crucial to prevent a damaging price war, ensuring robust patient care and supply, particularly during potential shortages.
Beyond the issue of discounts, Preis also advocated for increased remuneration for pharmacies. He pointed to the closure of 4,500 pharmacies – representing a 21 percent decline – since 2008. He expressed concern over the growing number of neighborhoods lacking pharmaceutical access. Preis noted that remuneration has remained largely unchanged for 13 years while operating costs, including energy and wages, have significantly increased, pushing more pharmacies toward financial instability.